EARLY DETECTION OF RECURRENCE IN HIGH-RISK HODGKIN LYMPHOMA IN FIRST COMPLETE REMISSION IMPROVES OUTCOME

EHA Library, Novella Pugliese, 215485

THE RISK OF LUNG CANCER IN HODGKIN LYMPHOMA SURVIVORS; A US POPULATION-BASED STUDY.

EHA Library, Mohamed Moussa, 215486

PROGNOSTIC VALUE OF FDG-PET QUANTITATIVE ASSESSMENT OF TUMOR REDUCTION BY ΔSUVMAX, ΔTMTV AND ΔTLG IN HODGKIN LYMPHOMA PATIENTS TREATED WITH AUTOLOGOUS HEMATOPOIEIC STEM CELL TRANSPLANTATION

EHA Library, Pilar Perlaza, 215487

DIFFERENTIAL DIAGNOSIS OF ENLARGED LYMPH NODE USING ULTRASOUND ELASTOSONOGRAPHY

EHA Library, Novella Pugliese, 215488

FRONTLINE BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY EXHIBITS SUPERIOR MODIFIED PROGRESSION-FREE SURVIVAL VS CHEMOTHERAPY ALONE IN PATIENTS WITH STAGE III OR IV HODGKIN LYMPHOMA: PHASE 3 ECHELON-1 STUDY

EHA Library, Andrea Gallamini, 215489

EARLY INTERIM POSITRON EMISSION TOMOGRAPHY (PET) EVALUATION OF RESPONSE AFTER 2 ABVD CYCLES IN ADVANCED HODGIN LYMPHOMA (HL): 8-YEAR EXPERIENCE IN HELLENIC DEPARTMENTS – CONCLUSIONS AND LIMITATIONS

EHA Library, Theodoros Vassilakopoulos, 215490

THE IMPACT OF CXCR4 MUTATION SUBTYPES IN THE RESPONSE AND PROGRESSION-FREE SURVIVAL OF PATIENTS WITH WALDENSTROM MACROGLOBULINEMIA TREATED WITH IBRUTINIB

EHA Library, Jorge Castillo, 215491

IBRUTINIB SHOWS PROLONGED PROGRESSION-FREE SURVIVAL IN SYMPTOMATIC, PREVIOUSLY TREATED PATIENTS WITH MYD88 MUTATED WALDENSTROM'S MACROGLOBULINEMIA: LONG-TERM FOLLOW-UP OF PIVOTAL TRIAL (NCT01614821).

EHA Library, Steven Treon, 215492

IMPROVED DEPTH OF RESPONSE WITH INCREASED FOLLOW-UP FOR PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) TREATED WITH BRUTON’S TYROSINE KINASE (BTK) INHIBITOR ZANUBRUTINIB

EHA Library, Judith Trotman, 215493

CHARACTERIZATION OF MALT LYMPHOMA WITH T(11;18): LONG-TERM FOLLOW-UP

EHA Library, Kosuke Toyoda, 215494

CLONAL B-CELL LYMPHOCYTOSIS OF MARGINAL ZONE ORIGIN (CBL-MZ): DESCRIPTION OF MAIN DISEASE FEATURES, CLINICAL COURSE AND OUTCOME IN A SERIES OF 98 CASES.

EHA Library, Christina Kalpadakis, 215495

OVERALL SURVIVAL OF MANTLE CELL LYMPHOMA (MCL) PATIENTS HAS BEEN SIGNIFICANTLY IMPROVED DURING THE TIME, MAINLY DUE TO THE RITUXIMAB MAINTENANCE IN ELDERLY POPULATION, REAL WORLD DATA.

EHA Library, Marek Trneny, 215496

IBRUTINIB FOR THE TREATMENT OF BING-NEEL SYNDROME

EHA Library, Jorge Castillo, 215497

IBRUTINIB MONOTHERAPY IN SYMPTOMATIC, TREATMENT-NAIVE PATIENTS WITH WALDENSTROM’S MACROGLOBULINEMIA.

EHA Library, Steven Treon, 215498

CLINICAL OUTCOME OF PATIENTS WITH LOCALIZED PRIMARY OCULAR ADNEXAL MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT) LYMPHOMA (OAL): LONG-TERM FOLLOW-UP RESULTS FROM A SINGLE-INSTITUTION OBSERVATIONAL STUDY.

EHA Library, Ritsuko Nakai, 215499

CD5-NEGATIVE MANTLE CELL LYMPHOMA: A DIAGNOSTIC CHALLENGE IN LEUKEMIC NON-NODAL CASES EXCLUSIVELY DIAGNOSED IN PERIPHERAL BLOOD

EHA Library, Sara Montesdeoca Romero, 215500

MARGINAL-ZONE LYMPHOMA WITH AND WITHOUT ASSOCIATION OF HEPATITIS C VIRUS INFECTION: CLINICAL CORRELATION AND TREATMENT RESULTS

EHA Library, Gayane Tumyan, 215501

STUDY OF THE DISSEMINATION PATTERNS AND CLONAL RELATIONSHIP IN DIFFERENT SITES IN MULTI-SITED MALT LYMPHOMAS. A SINGLE CENTRE ANALYSIS.

EHA Library, Maria Condom, 215502

GENETIC POLYMORPHISMS OF DC-SIGN AND L-FICOLIN ARE ASSOCIATED WITH INFECTIOUS COMPLICATIONS AFTER INDUCTION CHEMOTHERAPY: A VALIDATION STUDY IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Ulf Schnetzke, 215503

ONE-YEAR SURVIVAL AMONG PATIENTS WITH HEMATOLOGICAL DISEASE ADMITTED TO THE INTENSIVE CARE UNIT: A NATIONWIDE COHORT STUDY

EHA Library, Peter Asdahl, 215505

PREVALENCE AND RISK FACTORS OF RESISTANT GRAM-NEGATIVE BACILLI COLONIZATION AND INFECTION IN HOSPITALIZED HAEMATOLOGICAL PATIENTS

EHA Library, ANA PILAR GONZALEZ RODRIGUEZ, 215506

PEDIATRIC INTENSIVE CARE ADMISSIONS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Melpomeni Rompola, 215507

OUTCOME OF HIGH RISK FEBRILE NEUTROPENIC PATIENTS WITH GUT COLONIZATION WITH CARBAPENEM RESISTANT ENTEROBACTERIACEAE(CRE) IN SURVEILLANCE CULTURES "

EHA Library, Sweta Lunkad, 215508

COLONIZATION WITH MULTIDRUG-RESISTANT BACTERIA (MDRB) IS ASSOCIATED WITH COMPLICATIONS AND POOR OUTCOME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)

EHA Library, Chiara Maria DELLACASA, 215509

ANTIBIOTICS CAN SAFELY BE DISCONTINUED IN NEUTROPENIC HEMATOLOGY PATIENTS: A PROSPECTIVE COHORT

EHA Library, Zoe Van de Wyngaert, 215510

RISK OF INFECTIOUS COMPLICATIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN THE ERA OF NOVEL THERAPIES: A RETROSPECTIVE SINGLE INSTITUTION EXPERIENCE

EHA Library, Francesco Autore, 215511

THERAPEUTIC ADMINISTRATION OF IGM-ENRICHED IMMUNOGLOBULINS IMPROVES SURVIVAL IN HEMATOLOGICAL CANCER PATIENTS WITH SEVERE NEUTROPENIC SEPSIS

EHA Library, Linda Cheyenne Vaccari, 215512

TETANUS, DIPHTHERIA AND POLIO IMMUNITY AFTER CHEMOTHERAPY AND RITUXIMAB IN PATIENTS WITH LEUKEMIA AND LYMPHOMA

EHA Library, Sigrun Einarsdottir, 215513

THE DIAGNOSTIC UTILITY AND SENSITIVITY OF THE XPERT® MTB/RIF ASSAY IN DIAGNOSING MYCOBACTERIUM TUBERCULOSIS IN BONE MARROW ASPIRATE SPECIMENS

EHA Library, Nadhiya Subramony, 215514

Clinical and microbiological profile of bloodstream infections in patients with hematological malignancies and febrile neutropenia (PS 1210).

EHA Library, Haydee Bernard, 215515

VACCINATION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES OR SOLID TUMORS – GUIDELINE OF THE INFECTIOUS DISEASES WORKING PARTY (AGIHO) OF THE GERMAN SOCIETY FOR HEMATOLOGY AND MEDICAL ONCOLOGY (DGHO)

EHA Library, Sibylle Mellinghoff, 215517

CHARACTERISTICS OF HEMATOLOGICAL PATIENTS WITH BLOOD CULTURES PROVEN SEPSIS – EXPERIENCE OF ONE CENTER

EHA Library, Karla Misura Jakobac, 215518

CHARACTERISTICS AND OUTCOME OF POLYMICROBIAL BLOODSTREAM INFECTIONS (P-BSI) IN PATIENTS WITH HEMATOLOGICAL CANCER.

EHA Library, Maria Elena Zannier, 215519

IS ANTIMICROBIAL PROPHYLAXIS NECESSARY FOR LYMPHOMA PATIENTS? A SINGLE CENTRE, REAL-LIFE EXPERIENCE

EHA Library, Abdulkerim Yıldız, 215520

CASTLEMAN DISEASE WITH THE EXPERIENCE OVER 17 YEARS

EHA Library, Guray Saydam, 215521

EFFECTIVENESS OF DIFFERENT IRON ORAL FORMULATION IN IRON DEFICIENCY ANEMIA DUE TO GASTROINTESTINAL BLEEDING: MULTICENTRIC RANDOMIZED STUDY.

EHA Library, GIULIO GIORDANO, 215522

RENAL FUNCTION IN TRANSFUSION-DEPENDENT Β-THALASSEMIA PATIENTS: A DECADE OF FOLLOW-UP AND COMPARISON BETWEEN CHELATION REGIMES

EHA Library, Carina Levin, 215523

GENETIC STUDIES REVEAL NEW MUTATIONS IN THE CP GENE IN ACERULOPLASMINEMIA PATIENTS

EHA Library, Giacomo Marchi, 215524

DIAGNOSIS OF HEREDITARY HAEMATOLOGICAL DISEASES USING NEXT GENERATION SEQUENCING PANELS

EHA Library, Mayka Sanchez Fernandez, 215525

HEMATOPOIETIC IMPROVEMENT AFTER DEFERASIROX TREATMENT IN A CHILD WITH APLASTIC ANEMIA

EHA Library, Gizem Ersoy, 215526

TREATMENT WITH FERRIC CARBOXYMALTOSE FOR SEVERE IRON DEFICIENCY ANEMIA IN STABLE NOT ACTIVELY BLEEDING PATIENTS IN THE EMERGENCY DEPARTMENT

EHA Library, Irene Motta, 215527

IRON DEFICIENCY ANAEMIA – ZINC PROTOPORPHYRIN, A SIMPLE, FAST, INEXPENSIVE DIAGNOSTIC METHOD

EHA Library, João Gomes, 215528

STUDY OF A MEDICO-ECONOMIC ADVANTAGE IN USING NEW PARAMETERS OF CBC-DIFF-RETIC IN THE EARLY DETECTION OF IRON DEFICIENCY FOR DIALYSIS PATIENTS**

EHA Library, Elena Sukhacheva, 215529

ACERULOPLASMINAEMIA - THE EXTREMELY RARE ALSO EXISTS

EHA Library, João Gomes, 215530

IT TAKES A LOT OF IRON TO AVOID TRANSFUSION

EHA Library, Magda Jabbar Al-Obaidi, 215531

PANCREATIC IRON LOADING IN EMOGLOBINOPATHIES.

EHA Library, Alessia Pepe, 215532

CHR AND %HYPO: BETTER METHODS FOR ASSESSING FUNCTIONAL IRON DEFICIENCY IN CHRONIC KIDNEY DISEASE?

EHA Library, Laura Smith, 215533

GROWING IMPORTANCE OF FLOW CYTOMETRY (FCM) IN THE DIAGNOSTICS OF MYELODYSPLASTIC SYNDROMES: SENSITIVITY AND SPECIFICITY OF THE UP-TO-DATE SCORING SYSTEMS UNDER SPECIAL CONSIDERATION OF THE NEW IFSCORE

EHA Library, Uta OELSCHLAEGEL, 215534

EXPLORING THE LONG NON-CODING RNA TRANSCRIPTOME IN JUVENILE MYELOMONOCYTIC LEUKEMIA

EHA Library, Mattias Hofmans, 215535

A MIR-150 / TET3 PATHWAY REGULATES THE GENERATION OF MOUSE AND HUMAN NON-CLASSICAL MONOCYTE SUBSET

EHA Library, Dorothée Selimoglu-Buet, 215536

IMPACT OF RED BLOOD CELL TRANSFUSION RATE, ADJUSTED BY THERAPEUTIC INTERVENTIONS, ON PROGRESSION-FREE SURVIVAL IN LOWER RISK MDS PATIENTS WITHIN THE EUROPEAN LEUKEMIANET MDS REGISTRY

EHA Library, Louise de Swart, 215537

EXPRESSION PATTERN OF LONG-NONCODING RNAS ALTERS IN DIFFERENT FORMS OF MYELODYSPLASTIC SYNDROMES

EHA Library, Katarina Szikszai, 215538

MDS WITH P53 DYSFUNCTION: A NEW PROGNOSTIC AND PREDICTIVE CATEGORY. A STUDY FROM THE ITALIAN MDS CLINICAL NETWORK

EHA Library, Marianna rossi, 215539

A FLOW-CYTOMETRY SCORING SYSTEM OF ABNORMAL GRANULOCYTES AND MONOCYTES MATURATION PROFILES FOR DIAGNOSIS OF MYELODYSPLASTIC SYNDROMES

EHA Library, Nicolas Chapuis, 215540

ALTERED CARBONYLATION PATTERN IN MYELODISPLASTIC SYNDROMES

EHA Library, Alba Rodríguez-García, 215541

EXPRESSION LEVEL OF SPECIFIC MIRNAS BEFORE AZACITIDINE THERAPY INITIATION MAY PREDICT FUTURE EFFICACY OF THE TREATMENT IN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA

EHA Library, Michaela Dostalova Merkerova, 215542

MULTICENTRIC VALIDATION OF THE “MONOCYTE ASSAY” FOR CHRONIC MYELOMONOCYTIC LEUKEMIA DIAGNOSIS BY FLOW CYTOMETRY

EHA Library, Orianne Wagner-Ballon, 215543

CHARACTERIZATION AND DIFFERENTIAL EFFECTS OF MESENCHYMAL STROMAL CELL-DERIVED EXTRACELLULAR VESICLES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Manja Wobus, 215544

MYELODISPLASTIC SYNDROMES: MECHANISMS INVOLVED IN THE TRANSFORMATION TO ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Francisca Hernández Mohedo, 215545

COMPLETE BLOOD COUNT- BASED SCORE FOR THE DIAGNOSIS AND PROGNOSIS OF MYELODYSPLASTIC SYNDROMES IN CYTOPENIC PATIENTS

EHA Library, Marion Eveillard, 215546

AUTOPHAGY IN MYELODYSPLASTIC SYNDROMES: THE ROLE OF HIF-1A/REDD1 MOLECULAR PATHWAY

EHA Library, IOANNA STERGIOU, 215547

AN OPEN-LABEL PHASE 1 STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF DURVALUMAB IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AFTER TREATMENT WITH HYPOMETHYLATING AGENTS

EHA Library, Guillermo Garcia-Manero, 215548

SINGLE AGENT TALACOTUZUMAB IN ELDERLY HIGH-RISK MDS OR AML PATIENTS FAILING HYPOMETHYLATING AGENTS – RESULTS OF THE SAMBA STUDY BY THE EMSCO NETWORK

EHA Library, Uwe Platzbecker, 215549

HYPOMETHYLATING AGENTS ASSOCIATED INFECTIONS - SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

EHA Library, Liat Shargian, 215550

RESPONSE TO HYPOMETHYLATING AGENTS IMPROVES LONG-TERM OUTCOMES FOR LOWER-RISK PATIENTS WITH MYELODYSPLASTIC SYNDROME IN CASE-MATCHED COHORTS

EHA Library, Dongwon Baek, 215551

A SYSTEMATIC REVIEW PROVIDES LIMITED CLINICAL EVIDENCE FOR ADDITIONAL EFFICACY OF G-CSF + ESA COMPARED TO FULL-DOSE ESA ALONE IN THE TREATMENT OF ANEMIA IN PATIENTS WITH LOW-RISK MDS

EHA Library, Lucas Affentranger, 215552

LOW RISK MDS WITHOUT RING SIDEROBLASTS. CLINICAL AND BIOLOGICAL CHARACTERIZATION FROM THE SPANISH GROUP OF MDS.

EHA Library, Felix Lopez Cadenas, 215553

SEROTONIN RECEPTOR TYPE 1B CONSTITUTES A THERAPEUTIC TARGET FOR MDS AND CMML.

EHA Library, Antònia BANÚS MULET, 215554

INTENSIVE CHEMOTHERAPY (IC) IS MORE EFFECTIVE THAN HYPOMETHYLATING AGENTS (HMA) FOR THE TREATMENT OF YOUNGER PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) AND ELEVATED BONE MARROW BLASTS

EHA Library, Paolo Strati, 215555

FETAL HEMOGLOBIN INDUCTION DURING DECITABINE TREATMENT OF ELDERLY MDS/AML PATIENTS: A POTENTIAL DYNAMIC BIOMARKER FOR OUTCOME

EHA Library, Julia Stomper, 215556

CLINICAL IMPACT ON THE THERAPEUTIC STRATEGY ADAPTED TO THE MUTATIONAL PROFILE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME ASSOCIATED WITH DEL(5Q)

EHA Library, Carolina Alarcón-Payer, 215557

CHRONIC MYELOMONOCYTIC LEUKEMIA TREATED WITH 5-AZACYTIDINE. RESULTS FROM THE HELLENIC 5-AZACYTIDINE REGISTRY.

EHA Library, Panagiotis Diamantopoulos, 215558

OUTCOME OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND STABLE DISEASE DURING TREATMENT WITH AZACITIDINE: A REPORT FROM GRUPPO ROMANO MIELODISPLASIE (GROM) AND RETE EMATOLOGICA LOMBARDA (REL).

EHA Library, Luca Maurillo, 215559

PREDICTIVE FACTORS OF OVERALL SURVIVAL AND TREATMENT RESPONSE IN HIGH-RISK OLDER PATIENTS WITH MDS AND CMML UNDER HYPOMETHILATING AGENTS. LATIN-AMERICAN MDS GROUP - GLAM

EHA Library, Marcelo Iastrebner, 215560

IRON SUPPORT ENHANCES ERYTHROPOIETIN EFFECTIVENESS IN REFRACTORY ANEMIA WITH HIGH RETICULOCYTE COUNT, TRANSFERRIN SATURATION BELOW 30% AND HIGH LEVEL OF ERYPTOSIS.

EHA Library, GIULIO GIORDANO, 215561

SEVERE THROMBOCYTOPENIA AS A PREDICTOR OF SURVIVAL AND RESPONSE TO HYPOMETHYLATING AGENTS: DATA FROM A LATIN-AMERICAN COHORT

EHA Library, Carolina Lazzarino, 215563

TLR4 SIGNALING DRIVES MESENCHYMAL STEM CELLS (MSC) COMMITMENT TO PROMOTE TUMOR MICROENVIRONMENT TRANSFORMATION IN MULTIPLE MYELOMA

EHA Library, Cesarina Giallongo, 215564

BI-ALLELIC LOSS OF FAM46C BY CRISPR/CAS9 SYSTEM ENHANCES MYELOMA CELL GROWTH

EHA Library, KANASUGI JO, 215565

MOLECULAR SEGMENTATION OF MULTIPLE MYELOMA BY INTEGRATIVE MULTI-OMICS ANALYSIS

EHA Library, Maria Ortiz Estevez, 215566

SYSTEMATIC IDENTIFICATION OF PHARMACOGENOMICS INTERACTIONS MODULATING DRUG RESPONSES IN MULTIPLE MYELOMA

EHA Library, Muntasir Majumder, 215567

ADAR1-MEDIATED-NEIL1 EDITING IS OF BIOLOGICAL SIGNIFICANCE IN MULTIPLE MYELOMA

EHA Library, Phaik Ju Teoh, 215568

IRON INCREASES THE EFFICACY OF STANDARD MULTIPLE MYELOMA THERAPY IN TRANSGENIC VK*MYC MODEL

EHA Library, Jessica Bordini, 215569

BONE MARROW MACROPHAGES IN PATIENTS WITH MULTIPLE MYELOMA IN COMPLETE REMISSION RETAIN PRO-TUMOR M2 PHENOTYPE

EHA Library, Ester Lozano, 215570

PTC-028 DEMONSTRATES POTENT PRE-CLINICAL ACTIVITY AND PROVIDES A NOVEL OPPORTUNITY TO MODULATE BMI1 IN MULTIPLE MYELOMA

EHA Library, Heinz Ludwig, 215571

ARGININE DEPRIVATION SUSTAINS PLASMA CELL FITNESS AND BIOENERGETICS IN MULTIPLE MYELOMA

EHA Library, ALESSANDRA ROMANO, 215572

DEMETHYLATION SENSITISES T(4;14) MULTIPLE MYELOMA TO RAS-MAPK PATHWAY INHIBITION

EHA Library, Jay Hocking, 215573

CD96 (TACTILE) NEGATIVELY REGULATES THE CYTOTOXIC FUNCTIONS OF NATURAL KILLER CELLS AGAINST MULTIPLE MYELOMA

EHA Library, Michael O'Dwyer, 215574

GLUTAMINE-DEPENDENCE TARGETING BY ASPARAGINASE SIGNIFICANTLY INCREASES ANTI-MM ACTIVITY OF PROTEASOME INHIBITION

EHA Library, Paola Minetto, 215575

MITOCHONDRIAL ACTIVITY PLAYS A CRITICAL ROLE IN MULTIPLE MYELOMA RESISTANCE

EHA Library, Alejandra Ortiz, 215576

ELOTUZUMAB PROMOTES SELF-ENGAGEMENT OF SLAMF7 BETWEEN NATURAL KILLER AND MULTIPLE MYELOMA CELLS TO ENHANCE CYTOTOXICITY

EHA Library, Michael D. Robbins, 215577

CARFILZOMIB-INDUCED CARDIOTOXICITY: MOLECULAR MECHANISMS AND THE EMERGING ROLE OF METFORMIN AS A PROPHYLACTIC THERAPY

EHA Library, Evangelos Terpos, 215578

JAGGED1/2 INHIBITION PROMOTES TUMOR CELLS RESPONSE TO BORTEZOMIB IN A ZEBRAFISH MODEL OF MULTIPLE MYELOMA

EHA Library, Maria Teresa Palano, 215579

TGFΒ INHIBITION IN COMBINATION WITH CHEMOTHERAPY REPAIRS EXISTING LYTIC BONE LESIONS IN A NOVEL PLATEAU PHASE MODEL OF MULTIPLE MYELOMA

EHA Library, Andrew Chantry, 215580

MULTIPLE MYELOMA: SINGLE PLARFORM ABSOLUTE COUNT OF CIRCULATING PLASMA CELLS AT DIAGNOSIS CORRELATE WITH POOR PROGNOSIS PARAMETERS.

EHA Library, Vittorio Emanuele Muccio, 215581

MULTIPLE MYELOMA PATHOGENESIS: THE ROLE OF JUNB IN BONE MARROW ANGIOGENESIS

EHA Library, Stefano Malvestiti, 215582

TARGETED LIPOSOMAL MULTI-DRUG DELIVERY TO TUMOR-ASSOCIATED ENDOTHELIUM AS A NOVEL STRATEGY TO REVERSE MICROENVIRONMENT-INDUCED DRUG RESISTANCE IN MULTIPLE MYELOMA

EHA Library, Cinzia Federico, 215583

WNT/Β-CATENIN AND HEDGEHOG INHIBITORS AS THERAPEUTIC APPROACHES IN B-CELL NEOPLASMS

EHA Library, Ana Bela Sarmento Ribeiro, 215584

MULTIPLE MYELOMA INDUCES CHANGES IN BONE MARROW ADIPOCYTES IN VITRO AND IN VIVO

EHA Library, Michaela Reagan, 215585

PROTEIN KINASE CK1 ALPHA MODULATES PROSURVIVAL AUTOPHAGY IN MULTIPLE MYELOMA

EHA Library, Marilena Carrino, 215586

SERUM LIPID METABOLOMICS AS AN USEFUL BIOMARKER PREDICTING FOR THE EFFICACY OF　BORTEZOMIB TREATMENT AND PERIPHERAL NEUROPATHY IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Masaki Ri, 215587